Clinical Trial Detail

NCT ID NCT02024607
Title A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

colorectal adenocarcinoma

hepatocellular carcinoma

pancreatic adenocarcinoma

gastric adenocarcinoma

cholangiocarcinoma

Therapies

Capecitabine + Oxaliplatin

Bevacizumab + Napabucasin

Napabucasin + Regorafenib

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Napabucasin

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult

No variant requirements are available.